share_log

Compugen Ltd. (NASDAQ:CGEN) Just Reported Earnings, And Analysts Cut Their Target Price

Compugen Ltd. (NASDAQ:CGEN) Just Reported Earnings, And Analysts Cut Their Target Price

Compugen Ltd.(納斯達克股票代碼:CGEN)剛剛公佈了收益,分析師下調了目標價格
Simply Wall St ·  05/22 18:41

Compugen Ltd. (NASDAQ:CGEN) investors will be delighted, with the company turning in some strong numbers with its latest results. The results were impressive, with revenues of US$2.6m exceeding analyst forecasts by 111%, and statutory losses of US$0.08 were likewise much smaller than the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

Compugen Ltd.(納斯達克股票代碼:CGEN)的投資者將感到高興,該公司的最新業績帶來了一些強勁的數字。業績令人印象深刻,收入爲260萬美元,比分析師的預期高出111%,而0.08美元的法定虧損同樣比分析師的預測小得多。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

earnings-and-revenue-growth
NasdaqCM:CGEN Earnings and Revenue Growth May 22nd 2024
納斯達克股票代碼:CGEN 收益和收入增長 2024 年 5 月 22 日

Following the latest results, Compugen's two analysts are now forecasting revenues of US$37.0m in 2024. This would be a satisfactory 2.8% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 73% to US$0.05. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$37.9m and losses of US$0.13 per share in 2024. Although the revenue estimates have fallen somewhat, Compugen'sfuture looks a little different to the past, with a very promising decrease in the loss per share forecasts in particular.

根據最新業績,Compugen的兩位分析師現在預測2024年的收入爲3,700萬美元。與過去12個月相比,這將使收入令人滿意地增長2.8%。預計損失將大幅下降,萎縮73%,至0.05美元。然而,在最新業績公佈之前,分析師一直預測2024年的收入爲3790萬美元,每股虧損0.13美元。儘管收入預期有所下降,但Compugen的未來看起來與過去略有不同,特別是每股虧損預測的下降幅度非常令人鼓舞。

The consensus price target fell 6.2% to US$5.00, with the dip in revenue estimates clearly souring sentiment, despite the forecast reduction in losses.

儘管預計虧損會減少,但共識目標股價下跌6.2%,至5.00美元,收入預期的下降顯然惡化了市場情緒。

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Compugen's past performance and to peers in the same industry. We would highlight that Compugen's revenue growth is expected to slow, with the forecast 3.8% annualised growth rate until the end of 2024 being well below the historical 54% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 18% per year. Factoring in the forecast slowdown in growth, it seems obvious that Compugen is also expected to grow slower than other industry participants.

這些估計很有趣,但是在查看預測與Compugen過去的表現以及與同一行業的同行進行比較時,可以更粗略地描述一些細節。我們要強調的是,預計Compugen的收入增長將放緩,預計到2024年底的年化增長率爲3.8%,遠低於過去五年54%的歷史年增長率。相比之下,該行業中其他有分析師報道的公司的收入預計將以每年18%的速度增長。考慮到預期的增長放緩,很明顯,預計Compugen的增長速度也將低於其他行業參與者。

The Bottom Line

底線

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. With that said, earnings are more important to the long-term value of the business. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Compugen's future valuation.

要了解的最重要的一點是,分析師重申了明年的每股虧損預期。不利的一面是,他們還下調了收入預期,預測表明他們的表現將比整個行業差。話雖如此,收益對企業的長期價值更爲重要。共識目標股價大幅下降,最新業績似乎並未讓分析師放心,這導致對Compugen未來估值的估計降低。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At least one analyst has provided forecasts out to 2026, which can be seen for free on our platform here.

根據這種思路,我們認爲該業務的長期前景比明年的收益重要得多。至少有一位分析師提供了到2026年的預測,可以在我們的平台上免費查看。

It is also worth noting that we have found 4 warning signs for Compugen (1 is a bit concerning!) that you need to take into consideration.

還值得注意的是,我們已經發現了 Compugen 的 4 個警告信號(1 個有點令人擔憂!)這是你需要考慮的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論